Articles from GAXOS.AI INC.

Gaxos.ai Inc. Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Roseland, NJ, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,346,669 shares of its common stock at a purchase price of $3.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 1,346,669 shares of common stock. The warrants will have an exercise price of $3.00 per share, will be exercisable upon issuance and expire three years following the date of issuance. The closing of the offering is expected to occur on or about December 30, 2024, subject to the satisfaction of customary closing conditions.
By GAXOS.AI INC. · Via GlobeNewswire · December 27, 2024
Gaxos Labs Expands AI Capabilities for 3D Images with Meshy 4
Roseland, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Meshy 4 into their artificial intelligence solution for game developers and publishers, Gaxos Labs.
By GAXOS.AI INC. · Via GlobeNewswire · December 23, 2024
Gaxos.ai Inc. Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Roseland, NJ, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,449,277 shares of its common stock at a purchase price of $3.45 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to 1,449,277 shares of common stock. The warrants have an exercise price of $3.32 per share, are exercisable upon issuance and expire three years following the date of issuance. 
By GAXOS.AI INC. · Via GlobeNewswire · December 20, 2024
Gaxos.ai Inc. Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Roseland, NJ, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,449,277 shares of its common stock at a purchase price of $3.45 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 1,449,277 shares of common stock. The warrants will have an exercise price of $3.32 per share, will be exercisable upon issuance and expire three years following the date of issuance. The closing of the offering is expected to occur on or about December 20, 2024, subject to the satisfaction of customary closing conditions.
By GAXOS.AI INC. · Via GlobeNewswire · December 19, 2024
Gaxos Labs Expands Capabilities with Recraft AI Integration
Roseland, NJ, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Recraft AI into their artificial intelligence solution for game developers and publishers, Gaxos Labs.
By GAXOS.AI INC. · Via GlobeNewswire · December 12, 2024
Gaxos Labs Unveils Visual Editor for Godot Gaming Engine
Roseland, NJ, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company released a visual editor for Godot Engine for their artificial intelligence solution for game developers and publishers, Gaxos Labs. The Godot visual editor introduces a user-friendly interface that simplifies the process of embedding AI-driven features directly into game projects.
By GAXOS.AI INC. · Via GlobeNewswire · December 6, 2024
Gaxos Labs Adds Suno AI and ElevanLabs to Give Game Developers Speech, Sound, and Music Capabilities through Artificial Intelligence
Roseland, NJ, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Suno AI and ElevenLabs into their artificial intelligence solution for game developers and publishers, Gaxos Labs.
By GAXOS.AI INC. · Via GlobeNewswire · November 21, 2024
Gaxos Board of Directors Approves Bitcoin as Treasury Reserve Asset
Roseland, NJ, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, announced today that the Company’s Board of Directors approved the purchase of up to $1 million in Bitcoin. 
By GAXOS.AI INC. · Via GlobeNewswire · November 14, 2024
Gaxos to Participate in The AI Summit New York on December 11th to December 12th in New York City
Roseland, NJ, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming AI Summit New York on December 11th-12th in New York City.
By GAXOS.AI INC. · Via GlobeNewswire · November 5, 2024
Gaxos to Participate in the Game Industry Conference on October 24th to October 27th in Poznan, Poland
Roseland, NJ, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Game Industry Conference on October 24th - 27th in Poznan, Poland,
By GAXOS.AI INC. · Via GlobeNewswire · October 8, 2024
Gaxos.ai Inc. Announces Exercise of Warrants for $3.24 Million Gross Proceeds
Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 1,256,734 shares of its common stock originally issued in March 2024 and having an original exercise price of $5.50 per share, at a reduced exercise price of $2.58 per share. The issuance and sale of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-3 (File No. 333-278513).
By GAXOS.AI INC. · Via GlobeNewswire · September 20, 2024
Gaxos to Participate in Unity’s Upcoming Unite 2024 Conference on September 18th to 20th in Barcelona, Spain
Roseland, NJ, Sept. 13, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Unite 2024 Conference on September 18th - 20th in Barcelona, Spain.
By GAXOS.AI INC. · Via GlobeNewswire · September 13, 2024
Gaxos to Participate in Upcoming Devcom and Gamescom Conferences on August 18th to 25th in Cologne, Germany
Roseland, NJ, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Devcom Developer Conference on August 18th - Aug 20th and Gamescom Conference on August 21st – 25th in Cologne, Germany.
By GAXOS.AI INC. · Via GlobeNewswire · August 7, 2024
Gaxos Health Announces Commercial Launch
Significant Milestone as Company Transitions from Development to Revenue Generation.
By GAXOS.AI INC. · Via GlobeNewswire · July 30, 2024
Gaxos Health Announces Strategic Partnerships with Leading Testing Laboratories
Roseland, NJ, July 24, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has finalized partnerships with premier testing laboratories.
By GAXOS.AI INC. · Via GlobeNewswire · July 24, 2024
Gaxos Partners with Meshy to Deliver AI-Generated 3D Models in its Product for Game Developers and Publishers
Roseland, NJ, July 10, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it partnered with Meshy to deliver 3D assets in its AI solution for game developers and publishers.
By GAXOS.AI INC. · Via GlobeNewswire · July 10, 2024
Gaxos.AI Successfully Completes Development of AI Solution for Game Developers and Publishers
Roseland, NJ, June 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its gaming division, has successfully completed development of its AI solution for game developers and publishers.
By GAXOS.AI INC. · Via GlobeNewswire · June 25, 2024
Gaxos Health Expands Medical Advisory Board
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.
By GAXOS.AI INC. · Via GlobeNewswire · April 25, 2024
Gaxos.ai Regains Compliance with Nasdaq Listing Requirements
Roseland, NJ, March 26, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it received written notice from the NASDAQ Stock Market LLC (NASDAQ) on March 22, 2024, informing the Company that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on the NASDAQ Capital Market.
By GAXOS.AI INC. · Via GlobeNewswire · March 26, 2024
Gaxos.ai Inc. Announces Closing of $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules
Roseland, NJ, March 15, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it has closed its previously announced private placement for the purchase and sale of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a purchase price of $5.57 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants have an exercise price of $5.50 per share and are exercisable immediately upon issuance. The series A warrants expire five and one-half years from the date of issuance and short-term series B warrants expire twenty-four months from the date of issuance.
By GAXOS.AI INC. · Via GlobeNewswire · March 15, 2024
Gaxos.ai Inc. Announces $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules
Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a purchase price of $5.57 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants, in a private placement priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants will have an exercise price of $5.50 per share and will be exercisable immediately upon issuance. The series A warrants will expire five and one-half years from the date of issuance and the short-term series B warrants will expire twenty-four months from the date of issuance. The private placement is expected to close on or about March 15, 2024, subject to the satisfaction of customary closing conditions.
By GAXOS.AI INC. · Via GlobeNewswire · March 13, 2024
Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App
Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, “Ultiself,” in order to facilitate the development of its tech for Gaxos Health.
By GAXOS.AI INC. · Via GlobeNewswire · March 13, 2024
Gaxos.ai Inc. Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 8, 2024
Roseland, NJ, March 06, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it will effect a 1-for-12 reverse split of its issued and outstanding common stock effective as of 4:01pm Eastern Time on March 7, 2024. Commencing with the opening of trading on The Nasdaq Capital Market on March 8, 2024, the Company’s common stock will trade on a post-split basis under the same trading symbol, “GXAI”.
By GAXOS.AI INC. · Via GlobeNewswire · March 6, 2024
Gaxos Health Forms Medical Advisory Board to Support Launch of AI-powered Health and Wellness Solution
Roseland, NJ, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its health and wellness division, Gaxos Health, has formed a medical advisory board for providing invaluable insight into product development and creating strategic opportunities. The Company has appointed Dr. Nate Lebowitz, M.D. as the Chairman of the Advisory Board.
By GAXOS.AI INC. · Via GlobeNewswire · February 28, 2024
Gaxos Gaming to Launch AI Solution for Game Developers and Studios
Roseland, NJ, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its gaming division, Gaxos Gaming, will launch an artificial intelligence (AI) solution for game developers and studios.
By GAXOS.AI INC. · Via GlobeNewswire · February 16, 2024
Shareholder Update: Gaxos.AI Expands into AI-powered Health and Wellness Optimization Solutions
Roseland, NJ, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications various sectors, today announced a significant strategic expansion with Gaxos Health, a division dedicated to revolutionizing personal health and wellness.
By GAXOS.AI INC. · Via GlobeNewswire · January 23, 2024
UPDATE - Gaxos.AI to Expand with Artificial Intelligence Solutions for Health and Longevity
Roseland, NJ, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Gaxos.AI ("Gaxos" or the "Company"), today unveils a groundbreaking initiative to revolutionize the world of artificial intelligence. Building on its legacy in gaming, Gaxos is set to launch a visionary suite of artificial intelligence applications, uniquely designed to enhance mental and physical health, combat loneliness, and promote longevity.
By GAXOS.AI INC. · Via GlobeNewswire · January 16, 2024
Gaxos.AI to Expand with Artificial Intelligence Solutions for Health and Longevity
Roseland, NJ, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Gaxos.AI ("Gaxos" or the "Company"), today unveils a groundbreaking initiative to revolutionize the world of artificial intelligence. Building on its legacy in gaming, Gaxos is set to launch a visionary suite of artificial intelligence applications, uniquely designed to enhance mental and physical health, combat loneliness, and promote longevity.
By GAXOS.AI INC. · Via GlobeNewswire · January 12, 2024